AzTrials
AzTrials

HealthyNCT07781618

3D Foot Scanning and Customized 3D-Printed Foot Orthotics to Reduce Pressure on the Feet of Healthy Adults

A study testing Foot orthotics in people with Healthy, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The number of people with diabetes mellitus worldwide is increasing rapidly and is expected to rise to 439 million by 2030, or 7.7% of the total adult world population. The complications that can arise as a result of chronic diabetes represent a major problem in terms of clinical treatment, socio-economic consequences… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Foot orthotics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteBelgium
Study dates
23 Oct 2023to 19 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Reliability study:

The inclusion criteria:

  • Healthy population, age 18-65-year-old

The exclusion criteria:

  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder

Interventional study

The inclusion criteria:

  • Healthy population, age 18-65-year-old
  • Maximum weight of 90 kg
  • In-shoe M2 - M3 or central pattern bilateral or left/right

The exclusion criteria:

  • No injury of trauma of the lower limb in the past 6 months
  • No surgical procedures of the lower limbs or back in the past 6 months
  • Not pregnant at the time of testing
  • No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
  • No systemic or neurological disorder
  • Work does not require wearing safety shoes

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • KU Leuven Campus Bruges

    Bruges, West-Flanders, 8200

Other trials in Belgium

About this study

Official title: 3D Surface Scanning for the Measurement of the Human Foot and Customized 3D Printed Foot Orthotics for Plantar Off-loading in Healthy Participants

The number of people with diabetes mellitus worldwide is increasing rapidly and is expected to rise to 439 million by 2030, or 7.7% of the total adult world population. The complications that can arise as a result of chronic diabetes represent a major problem in terms of clinical treatment, socio-economic consequences and costs to the health care system. One of the most serious complications is a diabetic foot, which is characterized by neuropathy, ischemia and limited joint mobility and makes the foot vulnerable to foot ulcers and possible amputation. Various interventions are being investigated to prevent foot ulcers, including custom-made foot orthotics (CFOs), also known as foot orthoses. The latter allows the health professional to achieve a number of functional effects, of which the redistribution of the plantar pressure load is the most valuable, especially in patients with so-called risk feet.

The use of integrated computer-aided design and computer-aided manufacturing systems to produce CFOs has become increasingly popular over the past decade. In practice, this digital workflow comprises three different phases. First the (3D) foot shape of the patient is recorded, then the arch support is designed using special software and finally the device is made using a subtractive or additive manufacturing process (3D printing). As a result, it can be concluded that the first two phases are decisive for determining the geometric characteristics of a CFO, while the last phase is more critical for selecting the material properties.

Read more

As for the first phase, digital approaches were developed, such as 3D optical scanning that allows the researcher to scan body parts directly, providing a robust base for determining a CFO's geometrical features. The anthropometric foot parameters examined were worth investigating, but exclusively zero-dimensional in nature, providing limited insight when assessing the 3D fit of a custom made foot orthotic. Thus, current knowledge in this area remains scarce and further efforts are needed to better understand the role of 'geometrical features' in dose-response characteristics of custom orthotics.

With regard to the production phase, additive manufacturing or 3D printing is gaining more and more attention and could potentially set a new standard for manufacturing CFOs. Limited research shows that 3D printed CFOs can be used to reduce plantar pressure in healthy and diabetic populations. However, it is important to mention that these studies have not fully exploited the possible complex design options that the additive manufacturing process can provide, as their designs are very similar to those used in less polyvalent subtractive manufacturing processes. In addition, the relief properties of previously described CFOs are not or rarely driven by patient-specific plantar pressure data.

Research design Prospective monocentric observational study with a healthy, asymptomatic population.

Objectives The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults.

The study consists of two parts:

  • Reliability study
  • Observational study

Reliability study The methodological part of the current study consists of a reliability study with the focus on scanning the human foot. Since capturing the foot shape is the first step in the manufacturing process of custom insoles, it is important to use a reliable and objective scanning technique. This study aims to test the reliability, more specifically the intra-, inter-rater and test-retest reliability, of a portable, optical 3D scanner. In addition to the traditional zero-dimensional anthropometric measurements of the foot, mainly one-dimensional outcome measures will be studied.

Observational study In the observational part, the pressure distribution mechanism of several 3D-printed CFOs on the plantar pressure in asymptomatic patients with a so-called M2-M3 (metatarsal head of the second and third toe) pressure pattern at the level of the forefoot. There is a limited amount of literature on the effect of custom 3D-printed foot orthotics on plantar pressure distribution in healthy populations. In addition, the currently available literature appears to contain heterogeneous groups of participants with different plantar pressure distribution patterns, which complicates correct interpretation and generalization of the results, as the same orthosis designs are used for different pressure distribution patterns. During this study, several custom 3D-printed insoles, differentiated in padding density, structural architecture and geometric shape, will be applied to participants with M2-M3 forefoot patterns and then documented with a pressure distribution alg. Finally, a durability study will be conducted with the custom sole that provides the best relief from the peak pressure area of the forefoot.

Conditions
Healthy
Being tested
Foot orthotics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Foot orthoticsOther

    Foot orthotics

Study groups in NCT07781618
Study groupRoleWhat they receive
Within-Participant Orthotic ComparisonExperimentalThe study still has one experimental arm; the different orthoses are intervention conditions within that arm. It is a single-group, within-participant repeated-measures design.
Receives: Other: Foot orthotics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of custom-made foot orthotics on plantar pressure in people with a M2-3 pressure pattern.

    The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults with a M2-3 pressure pattern.

    Measured: From enrollment to the end of the of the test at 6 weeks.

  2. Reliability of 3D scanning

    To evaluate the inter-, intra-rater and test-retest reliability of 3D surface scanning for measuring and recording human foot shape in a non-weight bearing condition.

    Measured: From enrollment to final scanning after 3 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2026
  2. Study start23 Oct 2023
  3. Primary completion4 Jun 2026
  4. Study completion19 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Prospective monocentric observational study with a healthy, asymptomatic population.
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07781618
Sponsor's protocol ID
S67786
Status last verified
Aug 2026
First submitted
19 Aug 2026
Last updated
24 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Foot orthotics in people with Healthy, run by Universitaire Ziekenhuizen KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of custom-made foot orthotics on plantar pressure in people with a M2-3 pressure pattern. (time frame: From enrollment to the end of the of the test at 6 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07781618 | AzTrials